- Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer
-
Ryu JK
- KMID: 2373330
- Korean J Gastroenterol.
- 2015 Sep;66(3):150-153.
- doi: 10.4166/kjg.2015.66.3.150
Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy
-
Chung KH, Ryu JK, Son JH, Lee JW, Jang DK, Lee SH, Kim YT
- KMID: 2412198
- Gut Liver.
- 2017 Mar;11(2):298-305.
- doi: 10.5009/gnl16307
BACKGROUND/AIMS: Second-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
-
Moon DC, Lee HS, Lee YI, Chung MJ, Park JY, Park SW, Song SY, Chung JB, Bang S
- KMID: 2374156
- Yonsei Med J.
- 2016 Sep;57(5):1124-1130.
- doi: 10.3349/ymj.2016.57.5.1124
PURPOSE: Erlotinib-gemcitabine combined chemotherapy is considered as the standard treatment for unresectable pancreatic cancer. This study aimed to determine the clinical factors associated with response to this treatment. MATERIALS AND METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
